Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A2 receptor antibody-positive membranous nephropathy

Clinical Kidney Journal

Volumn 5, Issue 2, 2012, Pages 162-165

  Surindran, Sheena ^a   Ayalon, Rivka ^b   Hasan, Nazia ^c   Beck, Laurence H ^b   Salant, David J ^b   Barisoni, Laura ^a   Skolnik, Edward Y ^a,c   Beara Lasic, Lada ^a,d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ANCA vasculitis; antiphospholipase; membranous nephropathy

Indexed keywords

AUTOANTIBODY; CREATININE; CYCLOPHOSPHAMIDE; ENZYME ANTIBODY; FUROSEMIDE; HEMOGLOBIN; LISINOPRIL; METHYLPREDNISOLONE; MYELOBLASTIN; MYELOPEROXIDASE; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; PROTEINASE 3 ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; ERYTHROCYTE; FOLLOW UP; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOBLOTTING; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LEG EDEMA; LEUKOCYTE; LUNG CONGESTION; MALE; MEDICAL HISTORY; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; NEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED GLOMERULONEPHRITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; SCROTAL SWELLING; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

EID: 84885877309     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfr149     Document Type: Article

References (16)

1. Kain R, Exner M, Brandes R et al. Molecular mimicry in pauciimmune focal necrotizing glomerulonephritis. Nat Med 2008; 14: 1088-1096
2. Jennette JC, Falk RJ, Gasim AH. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens 2011; 20: 263-270
3. Beck LH Jr2, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21
4. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006; 17: 2264-2274 (Pubitemid 44141917)
5. Szpirt WM, Heaf JG, Petersen J. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis-a clinical randomized controlled trial. Nephrol Dial Transplant 2011; 26: 206-213
6. de Groot K, Harper L, Jayne DR et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 2009; 150: 670-680
7. Jha V, Ganguli A, Saha TK et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007; 18: 1899-1904 (Pubitemid 46870326)
8. Jones RB, Tervaert JW, Hauser T et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363: 211-220
9. Stone JH, Merkel PA, Spiera R et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363: 221-232
10. Beck LH Jr, Salant DJ. Membranous nephropathy: recent travels and new roads ahead. Kidney Int 2010; 77: 765-770
11. Debiec H, Ronco P. Nephrotic syndrome: a new specific test for idiopathic membranous nephropathy. Nat Rev Nephrol 2011; 7: 496-498
12. Luxton G, Langham R. The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis. Nephrology (Carlton) 2008; 13 (Suppl 2): S17-S23
13. Boomsma MM, Stegeman CA, van der Leij MJ et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000; 43: 2025-2033
14. Lionaki S, Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol 2007; 29: 459-474 (Pubitemid 350077264)
15. Nasr SH, Said SM, Valeri AM et al. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol 2009; 4: 299-308
16. Stanescu HC, Arcos-Burgos M, Medlar A et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364: 616-626